These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic. Sergio Tde O; Spiacci A; Zangrossi H Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701 [TBL] [Abstract][Full Text] [Related]
9. The CRF1 and the CRF2 receptor mediate recognition memory deficits and vulnerability induced by opiate withdrawal. Morisot N; Contarino A Neuropharmacology; 2016 Jun; 105():500-507. PubMed ID: 26907806 [TBL] [Abstract][Full Text] [Related]
10. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. McCarthy JR; Heinrichs SC; Grigoriadis DE Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797 [TBL] [Abstract][Full Text] [Related]
11. Don't stress about CRF: assessing the translational failures of CRF Spierling SR; Zorrilla EP Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716 [TBL] [Abstract][Full Text] [Related]
12. The effects of CRF and urocortins on the preference for social novelty of mice. Bagosi Z; Czébely-Lénárt A; Karasz G; Csabafi K; Jászberényi M; Telegdy G Behav Brain Res; 2017 May; 324():146-154. PubMed ID: 28189757 [TBL] [Abstract][Full Text] [Related]
13. The effects of CRF and urocortins on the sociability of mice. Bagosi Z; Karasz G; Czébely-Lénárt A; Csabafi K; Jászberényi M; Telegdy G Brain Res; 2017 May; 1663():114-122. PubMed ID: 28315311 [TBL] [Abstract][Full Text] [Related]
14. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910 [TBL] [Abstract][Full Text] [Related]
15. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress. Henry B; Vale W; Markou A J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071 [TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. Nozu T; Okumura T J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711 [TBL] [Abstract][Full Text] [Related]
17. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior. Fu Y; Neugebauer V J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885 [TBL] [Abstract][Full Text] [Related]
18. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum. Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313 [TBL] [Abstract][Full Text] [Related]
19. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Miguel TT; Nunes-de-Souza RL Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867 [TBL] [Abstract][Full Text] [Related]
20. Similar effect of CRF Spinieli RL; Leite-Panissi CRA Brain Res Bull; 2018 Mar; 137():187-196. PubMed ID: 29246866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]